U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

2012
608
Substance Class
Concept
Record UNII
5BSH2G9BH8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SURFAXIN
Preferred Name English
LUCINACTANT
ORANGE BOOK   USAN   WHO-DD  
USAN  
Official Name English
KL-SURFACTANT
Common Name English
LUCINACTANT (DIPALMITOYLPHOSPHATIDYLCHOLINEPALMITIC ACIDSINAPULTIDE ACETATESODIUM PALMITOYLOLEOYLPHOSPATIDYLGLYCEROL)
Common Name English
KL4-SURFACTANT
Code English
ATI-02
Code English
Lucinactant [WHO-DD]
Common Name English
LUCINACTANT [USAN]
Common Name English
ATI 02
Code English
LUCINACTANT [ORANGE BOOK]
Common Name English
A SURFACTANT FORMULATION COMPRISED OF SINAPULTIDE, COLFOSCERIL PALMITATE (DIPALMITOYLPHOSPHATIDYLCHOLINE (DPPC)), PALMITOYLOLEAYLPHOSPHATIDYL GLYCEROL, SODIUM SALT (POPG), AND PALMITIC ACID
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 99796
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
FDA ORPHAN DRUG 91395
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
FDA ORPHAN DRUG 89995
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
FDA ORPHAN DRUG 208705
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
FDA ORPHAN DRUG 211405
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
FDA ORPHAN DRUG 318910
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
Code System Code Type Description
FDA UNII
5BSH2G9BH8
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
WIKIPEDIA
Lucinactant
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
MESH
C502722
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
DRUG BANK
DB04897
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
NCI_THESAURUS
C172611
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
USAN
RR-136
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
DRUG CENTRAL
4232
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
CAS
825600-90-6
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
NO STRUCTURE GIVEN
EPA CompTox
DTXSID601027853
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
RXCUI
1293254
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
ChEMBL
CHEMBL1963685
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
SMS_ID
300000001960
Created by admin on Wed Apr 02 18:52:35 GMT 2025 , Edited by admin on Wed Apr 02 18:52:35 GMT 2025
PRIMARY
Related Record Type Details
Human lung surfactant
TARGET->MIMETIC
LUCINACTANT
SPECIFIED SUBSTANCE -> _
Definition References
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966